HARIBHAKTI KAMLESH 4
4 · ABLE LABORATORIES INC · Filed Jan 3, 2005
Insider Transaction Report
Form 4
HARIBHAKTI KAMLESH
Director - Product Development
Transactions
- Conversion
Common Stock
2004-12-30+14,675→ 16,342 total - Conversion
Series Q Preferred Stock
2004-12-30−250→ 0 total→ Common Stock (14,675 underlying)
Footnotes (3)
- [F1]Shares acquired upon conversion of Series Q Preferred Stock.
- [F2]Each share of Series Q Preferred Stock converts into approximately 58.70 shares of common stock.
- [F3]Immediately.